Data from a study into a potential blood test for breast cancer is "encouraging" as it would make early detection of the disease in all women much easier, a science chief has said.
Lead researcher on the study, Professor Martin Widschwendter, from University College London, said:
We identified an epigenetic signature in women with a mutated BRCA1 gene that was linked to increased cancer risk and lower survival rates.
Surprisingly, we found the same signature in large cohorts of women without the BRCA1 mutation and it was able to predict breast cancer risk several years before diagnosis.
The data is encouraging since it shows the potential of a blood-based epigenetic test to identify breast cancer risk in women without known predisposing genetic mutations.
More top news
In an embarrassing setback for the president, Republicans failed to reach the number of votes to pass his new healthcare act into law.
It will feel pleasantly warm in the sunshine, with temperatures reaching 12 or 13 Celsius (54 to 55F).
Some of Britain's biggest stars of the stage and screen will be honoured at Buckingham Palace later today.